EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor pathological response after neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study

Kian Chin, Amalia H Landén, Anikó Kovács, Fredrik Wärnberg, Maria Ekholm, Per Karlsson, Roger Olofsson Bagge

Breast Cancer Research and Treatment · 2024

DOI: 10.1007/s10549-024-07334-6 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Breast Cancer Research and Treatment, 2024. Verfasst von Kian Chin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Sciences, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden. kian.chin@vgregion.se. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Breast Neoplasms, Neoadjuvant Therapy, Axilla. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stiftelsen Assar Gabrielssons Fond, Anna-Lisa och Bror Björnssons Stiftelse, Bröstcancer Förbundet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Tumor-infiltrating lymphocytes (TILs) can predict complete pathological response (pCR) of tumor in the breast but not so well-defined in the axilla after neoadjuvant chemotherapy. Since axillary surgery is being increasingly de-escalated after NACT, we aimed to investigate the relationship between TILs and pCR in the axilla and breast, as well as survival amongst NACT patients.

Methods

Clinicopathological data on patients who underwent NACT between 2013 and 2020 were retrospectively examined. Specifically, pre-TILs (before NACT), post-TILs (after NACT) and ΔTIL (changes in TILs) were assessed. Primary endpoint was pCR and secondary endpoints were breast cancer-free interval (BCFI) and overall survival (OS).

Results

Two hundred and twenty patients with nodal metastases were included. Overall axillary and breast pCR rates were 42.7% (94/220) and 39.1% (86/220), respectively, whereas the combined pCR rate was 32.7% (72/220). High pre-TILs (OR 2.03, 95% CI 1.02–4.05; p = 0.04) predicted axillary pCR whereas, high post-TILs (OR 0.33, 95% CI 0.14–0.76; p = 0.009) and increased ΔTILs (OR 0.25, 95% CI 0.08–0.79; p = 0.02) predicted non-axillary pCR. TILs were not a significant predictor for BCFI and OS.

Conclusions

This study supports the potential use of pre-TILs to select initially node-positive patients for axillary surgical de-escalation after NACT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocytes, Tumor-InfiltratingBreast NeoplasmsNeoadjuvant TherapyAxillaHumansFemaleRetrospective StudiesMiddle AgedAdultPrognosisAgedTreatment OutcomeLymphatic MetastasisAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, Adjuvant

Stichwörter der Autor:innen

Axillary lymph node dissectionBreast cancerNeoadjuvant chemotherapyTumor responseTumor-infiltrating lymphocytes

Autor:innen und Institutionen

  • Institute of Clinical Sciences, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden. kian.chin@vgregion.se.
  • Department of Surgery, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden. kian.chin@vgregion.se.
  • Department of Oncology, Institute of Clinical Sciences in Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Institute of Clinical Sciences, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.
  • Department of Oncology, Ryhov County Hospital, Jönköping, Sweden.

Förderung

  • Stiftelsen Assar Gabrielssons Fond
  • Anna-Lisa och Bror Björnssons Stiftelse
  • Bröstcancer Förbundet
  • University of Gothenburg

Zitieren

APA

Chin, K., Landén, A. H., Kovács, A., Wärnberg, F., Ekholm, M., Karlsson, P., & Olofsson Bagge, R. (2024). Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor pathological response after neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07334-6

Vancouver

Chin K, Landén AH, Kovács A, Wärnberg F, Ekholm M, Karlsson P, et al. Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor pathological response after neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study. Breast Cancer Research and Treatment. 2024. doi:10.1007/s10549-024-07334-6

BibTeX
@article{Chin2024,
  author = {Chin, Kian and Landén, Amalia H and Kovács, Anikó and Wärnberg, Fredrik and Ekholm, Maria and Karlsson, Per and Olofsson Bagge, Roger},
  title = {Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor pathological response after neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study},
  journal = {Breast Cancer Research and Treatment},
  year = {2024},
  doi = {10.1007/s10549-024-07334-6}
}
Kostenlos starten →